Zydus Wellness Limited develops, produces, markets, and distributes health and wellness products in India. More Details
Reasonable growth potential with questionable track record.
Share Price & News
How has Zydus Wellness's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 531335's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: 531335 underperformed the Indian Food industry which returned 17.7% over the past year.
Return vs Market: 531335 exceeded the Indian Market which returned -0.8% over the past year.
Price Volatility Vs. Market
How volatile is Zydus Wellness's share price compared to the market and industry in the last 5 years?
Simply Wall St News
Is Zydus Wellness undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 531335 (₹1767.5) is trading above our estimate of fair value (₹775.18)
Significantly Below Fair Value: 531335 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 531335 is poor value based on its PE Ratio (67.7x) compared to the IN Food industry average (14.1x).
PE vs Market: 531335 is poor value based on its PE Ratio (67.7x) compared to the Indian market (16.1x).
Price to Earnings Growth Ratio
PEG Ratio: 531335 is poor value based on its PEG Ratio (2x)
Price to Book Ratio
PB vs Industry: 531335 is overvalued based on its PB Ratio (2.9x) compared to the IN Food industry average (1.2x).
How is Zydus Wellness forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 531335's forecast earnings growth (33.9% per year) is above the savings rate (7.2%).
Earnings vs Market: 531335's earnings (33.9% per year) are forecast to grow faster than the Indian market (26.2% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 531335's revenue (12.4% per year) is forecast to grow faster than the Indian market (11.7% per year).
High Growth Revenue: 531335's revenue (12.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 531335's Return on Equity is forecast to be low in 3 years time (7.1%).
How has Zydus Wellness performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 531335 has high quality earnings.
Growing Profit Margin: 531335's current net profit margins (8.9%) are lower than last year (16.9%).
Past Earnings Growth Analysis
Earnings Trend: 531335's earnings have grown by 10.9% per year over the past 5 years.
Accelerating Growth: 531335's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 531335 had negative earnings growth (-32.6%) over the past year, making it difficult to compare to the Food industry average (13.2%).
Return on Equity
High ROE: 531335's Return on Equity (4.3%) is considered low.
How is Zydus Wellness's financial position?
Financial Position Analysis
Short Term Liabilities: 531335's short term assets (₹7.8B) exceed its short term liabilities (₹6.0B).
Long Term Liabilities: 531335's short term assets (₹7.8B) do not cover its long term liabilities (₹15.3B).
Debt to Equity History and Analysis
Debt Level: 531335's debt to equity ratio (43.9%) is considered high.
Reducing Debt: Insufficient data to determine if 531335's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 531335's debt is not well covered by operating cash flow (17.1%).
Interest Coverage: 531335's interest payments on its debt are not well covered by EBIT (2x coverage).
What is Zydus Wellness's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 531335's dividend (0.28%) isn’t notable compared to the bottom 25% of dividend payers in the Indian market (0.56%).
High Dividend: 531335's dividend (0.28%) is low compared to the top 25% of dividend payers in the Indian market (2.28%).
Stability and Growth of Payments
Stable Dividend: 531335's dividend payments have been volatile in the past 10 years.
Growing Dividend: 531335's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its low payout ratio (19.2%), 531335's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Tarun Arora (48 yo)
Mr. Tarun G. Arora has been Chief Executive Officer of Zydus Wellness Limited since January 2019 and is instrumental in accelerating the growth on back of innovations, expanding the geographies for the bus ...
CEO Compensation Analysis
Compensation vs Market: Tarun's total compensation ($USD149.45K) is below average for companies of similar size in the Indian market ($USD574.24K).
Compensation vs Earnings: Tarun's compensation has been consistent with company performance over the past year.
|CEO & Whole Time Director||1.67yrs||₹11.00m||0.0017% |
|Chief Financial Officer||2.58yrs||₹12.02m||0.000010% |
|Company Secretary & Compliance Officer||1.58yrs||₹1.13m||no data|
Experienced Management: 531335's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
|CEO & Whole Time Director||1.67yrs||₹11.00m||0.0017% |
|Non-Executive Chairman||6.17yrs||₹500.00k||0.00092% |
|Non-Executive Director||14.17yrs||₹800.00k||0.011% |
|Independent Director||1.5yrs||₹450.00k||no data|
|Non-Executive & Independent Director||3.83yrs||₹450.00k||no data|
|Nominee Director||1.67yrs||no data||no data|
|Independent Director||1.83yrs||₹900.00k||0.00030% |
|Independent Director||1.5yrs||₹500.00k||no data|
Experienced Board: 531335's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Zydus Wellness Limited's company bio, employee growth, exchange listings and data sources
- Name: Zydus Wellness Limited
- Ticker: 531335
- Exchange: BSE
- Founded: 1994
- Industry: Packaged Foods and Meats
- Sector: Food, Beverage & Tobacco
- Market Cap: ₹102.748b
- Shares outstanding: 59.79m
- Website: https://www.zyduswellness.in
- Zydus Wellness Limited
- Zydus Corporate Park
- Scheme No. 63, Survey No. 536
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|531335||BSE (Mumbai Stock Exchange)||Yes||Equity Shares||IN||INR||Feb 2002|
|ZYDUSWELL||NSEI (National Stock Exchange of India)||Yes||Equity Shares||IN||INR||Feb 2002|
Zydus Wellness Limited develops, produces, markets, and distributes health and wellness products in India. The company provides sugar substitute products under the Sugar Free Gold, Sugar Free Natura, and S ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/09/23 19:17|
|End of Day Share Price||2020/09/23 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.